查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1704588

2025年全球体外诊断酵素市场报告

In Vitro Diagnostics Enzymes Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

由于癌症发病率的上升，体外诊断酶市场预计将经历显着增长。癌症是指一组以细胞异常生长分裂为特征的疾病，对健康组织构成威胁。导致癌症发生率上升的因素包括感染疾病、免疫系统功能障碍和荷尔蒙影响。体外诊断 (IVD) 酶在整体癌症护理范围内的各种诊断和监测检测中发挥着重要作用，从早期检测和诊断到治疗方法选择、监测和个人化医疗。例如，世界卫生组织 (WHO) 预测，到 2050 年，新发生癌症病例将比 2022 年增加 77%，这凸显了癌症管理对体外诊断酶的需求日益增加。

体外诊断酶市场的主要企业正在投资自体免疫疾病检测套件等创新产品，以保持其在市场中的地位。这些套件旨在检测免疫系统错误攻击身体组织的自体免疫疾病。例如，NeoDx Biotech Labs Pvt Ltd. 最近推出了一种用于检测自体免疫疾病的 IVD套件，该试剂盒结合了免疫测量、分子诊断和抗体检测方法等先进技术。该套件具有较高的敏感性和特异性，可帮助临床医师快速且准确地诊断自体免疫疾病。

2023 年 2 月，SD Biosensors Inc. 和 SJL Partners LLC 以 ​​15.3 亿美元收购了 Meridian Biosciences Inc.。此次收购使 SD Biosensors 能够利用 Meridian 在诊断、免疫学和分子测试材料方面的专业知识，用于一系列应用。美国Meridian Bioscience公司因其在体外诊断酶和相关技术方面的贡献而闻名。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球体外诊断酵素PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球体外诊断酵素市场：增长率分析
  • 全球体外诊断酶市场表现：规模与成长，2019-2024
  • 全球体外诊断酶市场预测：规模与成长，2024-2029，2034F
  • 体外诊断酵素的全球总目标市场（TAM）

第六章市场区隔

  • 全球体外诊断酶市场（按酶类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 蛋白酶
  • 聚合酵素和转录酶
  • 核糖核酸酶
  • 其他酵素类型
  • 全球体外诊断酶市场：按疾病类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 感染疾病
  • 糖尿病
  • 肿瘤学
  • 心臟病学
  • 肾臟病学
  • 自体免疫疾病
  • 其他类型的疾病
  • 全球体外诊断酵素市场技术、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 组织学检测
  • 分子诊断
  • 临床化学
  • 其他技术
  • 全球体外诊断酵素市场最终用途、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 製药和生物技术
  • 医院和诊断实验室
  • 合约研究组织（CRO）
  • 学术实验室
  • 全球体外诊断酵素市场蛋白酶细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 胰蛋白酶
  • 胃蛋白酶
  • 蛋白酶K
  • 全球体外诊断酶市场聚合酵素和转录酶细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • DNA聚合酵素
  • RNA聚合酵素
  • 逆转录酶
  • 全球体外诊断酶市场核糖核酸酶细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • RNase A
  • RNase H
  • 全球体外诊断酶市场，按其他酶类型细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 脱氢酶
  • 脂肪酶
  • 连接酶

第七章 区域和国家分析

  • 全球体外诊断酵素市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球体外诊断酵素市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 体外诊断酶市场：竞争格局
  • 体外诊断酶市场：公司简介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • Grifols SA
  • Hologic Inc.
  • Illumina Inc.
  • Mindray Medical International Limited
  • PerkinElmer Inc.
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • DiaSorin SpA
  • Promega Corporation
  • Randox Laboratories Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年体外诊断酵素市场：提供新机会的国家
  • 2029年体外诊断酵素市场：细分市场带来新机会
  • 2029年体外诊断酵素市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r30450

In vitro diagnostics (IVD) enzymes are specialized proteins used in diagnostic tests conducted outside the living organism, typically in a laboratory setting. These enzymes catalyze specific biochemical reactions that help detect, quantify, or monitor the presence of various substances, including pathogens, biomarkers, or other molecules relevant to diagnosing diseases.

The main enzyme types in the in vitro diagnostics enzymes market are proteases, polymerase and transcriptase, ribonuclease, and other enzyme types. Proteases refer to enzymes that catalyze the breakdown of proteins into smaller peptides or amino acids. Various disease types are targeted, including infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, and others. These enzymes are utilized in various technologies such as histology assays, molecular diagnostics, clinical chemistry, and others, and are used by end users such as pharmaceutical and biotech companies, hospitals and diagnostic labs, contract research organizations (CROs), and academic labs.

The in vitro diagnostics enzymes market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostics enzymes market statistics, including in vitro diagnostics enzymes industry global market size, regional shares, competitors with an in vitro diagnostics enzymes market share, detailed in vitro diagnostics enzymes market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro diagnostics enzymes industry. This in vitro diagnostics enzymes research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in vitro diagnostics enzymes market size has grown strongly in recent years. It will grow from $2.14 billion in 2024 to $2.32 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing incidence of diseases such as cancer and HIV/AIDS, growing need for diagnostic testing and monitoring of age-related diseases, shifts in lifestyle factors, including diet and physical activity, rise in approval of new diagnostic assays and products by regulatory authorities, and higher healthcare expenditures globally.

The in vitro diagnostics enzymes market size is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing focus on personalized healthcare, growing healthcare infrastructure, rising disposable incomes in emerging markets, rise in collaborations between companies and research institutions, and increasing demand for rapid and convenient diagnostic solutions. Major trends in the forecast period include the adoption of microfluidics technologies, development of novel enzyme substrates and detection methods, use of point-of-care molecular diagnostic platforms integrated enzyme-based amplification techniques, integration of CRISPR-based technologies with enzyme assays, use of liquid biopsy techniques, and utilization of advanced data analytics and bioinformatics tools.

The in vitro diagnostics enzymes market is expected to grow significantly due to the rising prevalence of cancer. Cancer refers to a group of diseases characterized by abnormal cell growth and division, posing a threat to healthy tissues. Factors contributing to the increased prevalence of cancer include infectious agents, immune system dysfunctions, and hormonal influences. In vitro diagnostics (IVD) enzymes play a crucial role in various diagnostic and monitoring assays across the cancer care continuum, from early detection and diagnosis to treatment selection, monitoring, and personalized medicine. For example, the World Health Organization (WHO) projects a 77% increase in new cancer cases by 2050 compared to 2022, highlighting the growing need for in vitro diagnostics enzymes in cancer management.

Leading companies in the in vitro diagnostics enzymes market are investing in innovative products such as autoimmune disorder detection kits to maintain their market position. These kits are designed to detect autoimmune diseases, where the immune system mistakenly attacks the body's tissues. For instance, NeoDx Biotech Labs Pvt Ltd. recently launched an IVD kit for detecting autoimmune disorders, incorporating advanced technologies such as immunoassays, molecular diagnostics, and antibody detection methods. This kit offers high sensitivity and specificity, enabling clinicians to swiftly and accurately diagnose autoimmune conditions.

In February 2023, SD Biosensor Inc. and SJL Partners LLC acquired Meridian Bioscience Inc. for $1.53 billion. This acquisition allows SD Biosensor to leverage Meridian's expertise in diagnostic products and raw materials for immunological and molecular tests across various applications. Meridian Bioscience Inc., based in the US, is known for its contributions to in vitro diagnostic enzymes and related technologies.

Major companies operating in the in vitro diagnostics enzymes market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., Mindray Medical International Limited, PerkinElmer Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin SpA, Promega Corporation, Randox Laboratories Ltd., Meridian Bioscience Inc., Fujirebio Diagnostics Inc., Sekisui Diagnostics LLC, Trivitron Healthcare, Codexis Inc., Amicogen Inc., EKF Diagnostics Holdings plc, Advanced Enzymes Technologies Ltd., Biocatalysts Ltd., Alpha Laboratories Ltd.

North America was the largest region in the in vitro diagnostics enzymes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostics enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro diagnostics (IVD) enzymes market consists of revenues earned by entities by providing services such as enzyme engineering, custom enzyme production, validation services, promega custom assay services, and bio-techne enzyme solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro diagnostics (IVD) enzymes market also includes sales of Taq DNA polymerase, reverse transcriptase, alkaline phosphatase (ALP), horseradish peroxidase (HRP), DNA ligase, NEB enzyme products, and sigma-Aldrich diagnostic enzymes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics Enzymes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostics enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro diagnostics enzymes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Enzyme Type: Proteases; Polymerase And Transcriptase; Ribonuclease; Other Enzyme Types
  • 2) By Disease Type: Infectious Disease; Diabetes; Oncology; Cardiology; Nephrology; Autoimmune Diseases; Other Disease Types
  • 3) By Technology: Histology Assays; Molecular Diagnostics; Clinical Chemistry; Other Technologies
  • 4) By End Use: Pharma And Biotech; Hospital And Diagnostic Labs; Contract Research Organizations (CROs); Academic Labs
  • Subsegments:
  • 1) By Proteases: Trypsin; Pepsin; Proteinase K
  • 2) By Polymerase And Transcriptase: DNA Polymerase; RNA Polymerase; Reverse Transcriptase
  • 3) By Ribonuclease: RNase A; RNase H
  • 4) By Other Enzyme Types: Dehydrogenases; Lipases; Ligases
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostics Enzymes Market Characteristics

3. In Vitro Diagnostics Enzymes Market Trends And Strategies

4. In Vitro Diagnostics Enzymes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global In Vitro Diagnostics Enzymes Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In Vitro Diagnostics Enzymes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In Vitro Diagnostics Enzymes Market Growth Rate Analysis
  • 5.4. Global In Vitro Diagnostics Enzymes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In Vitro Diagnostics Enzymes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In Vitro Diagnostics Enzymes Total Addressable Market (TAM)

6. In Vitro Diagnostics Enzymes Market Segmentation

  • 6.1. Global In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proteases
  • Polymerase And Transcriptase
  • Ribonuclease
  • Other Enzyme Types
  • 6.2. Global In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Disease
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Other Disease Types
  • 6.3. Global In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Histology Assays
  • Molecular Diagnostics
  • Clinical Chemistry
  • Other Technologies
  • 6.4. Global In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharma And Biotech
  • Hospital And Diagnostic Labs
  • Contract Research Organizations (CROs)
  • Academic Labs
  • 6.5. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Proteases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trypsin
  • Pepsin
  • Proteinase K
  • 6.6. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Polymerase And Transcriptase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA Polymerase
  • RNA Polymerase
  • Reverse Transcriptase
  • 6.7. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Ribonuclease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • RNase A
  • RNase H
  • 6.8. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Other Enzyme Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dehydrogenases
  • Lipases
  • Ligases

7. In Vitro Diagnostics Enzymes Market Regional And Country Analysis

  • 7.1. Global In Vitro Diagnostics Enzymes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In Vitro Diagnostics Enzymes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Vitro Diagnostics Enzymes Market

  • 8.1. Asia-Pacific In Vitro Diagnostics Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Vitro Diagnostics Enzymes Market

  • 9.1. China In Vitro Diagnostics Enzymes Market Overview
  • 9.2. China In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Vitro Diagnostics Enzymes Market

  • 10.1. India In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Vitro Diagnostics Enzymes Market

  • 11.1. Japan In Vitro Diagnostics Enzymes Market Overview
  • 11.2. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Vitro Diagnostics Enzymes Market

  • 12.1. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Vitro Diagnostics Enzymes Market

  • 13.1. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Vitro Diagnostics Enzymes Market

  • 14.1. South Korea In Vitro Diagnostics Enzymes Market Overview
  • 14.2. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In Vitro Diagnostics Enzymes Market

  • 15.1. Western Europe In Vitro Diagnostics Enzymes Market Overview
  • 15.2. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In Vitro Diagnostics Enzymes Market

  • 16.1. UK In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In Vitro Diagnostics Enzymes Market

  • 17.1. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In Vitro Diagnostics Enzymes Market

  • 18.1. France In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In Vitro Diagnostics Enzymes Market

  • 19.1. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In Vitro Diagnostics Enzymes Market

  • 20.1. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In Vitro Diagnostics Enzymes Market

  • 21.1. Eastern Europe In Vitro Diagnostics Enzymes Market Overview
  • 21.2. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In Vitro Diagnostics Enzymes Market

  • 22.1. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In Vitro Diagnostics Enzymes Market

  • 23.1. North America In Vitro Diagnostics Enzymes Market Overview
  • 23.2. North America In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In Vitro Diagnostics Enzymes Market

  • 24.1. USA In Vitro Diagnostics Enzymes Market Overview
  • 24.2. USA In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In Vitro Diagnostics Enzymes Market

  • 25.1. Canada In Vitro Diagnostics Enzymes Market Overview
  • 25.2. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In Vitro Diagnostics Enzymes Market

  • 26.1. South America In Vitro Diagnostics Enzymes Market Overview
  • 26.2. South America In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In Vitro Diagnostics Enzymes Market

  • 27.1. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In Vitro Diagnostics Enzymes Market

  • 28.1. Middle East In Vitro Diagnostics Enzymes Market Overview
  • 28.2. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In Vitro Diagnostics Enzymes Market

  • 29.1. Africa In Vitro Diagnostics Enzymes Market Overview
  • 29.2. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In Vitro Diagnostics Enzymes Market Competitive Landscape And Company Profiles

  • 30.1. In Vitro Diagnostics Enzymes Market Competitive Landscape
  • 30.2. In Vitro Diagnostics Enzymes Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. In Vitro Diagnostics Enzymes Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Agilent Technologies Inc.
  • 31.3. Grifols SA
  • 31.4. Hologic Inc.
  • 31.5. Illumina Inc.
  • 31.6. Mindray Medical International Limited
  • 31.7. PerkinElmer Inc.
  • 31.8. bioMerieux SA
  • 31.9. QuidelOrtho Corporation
  • 31.10. Sysmex Corporation
  • 31.11. Bio-Rad Laboratories Inc.
  • 31.12. Qiagen N.V.
  • 31.13. DiaSorin SpA
  • 31.14. Promega Corporation
  • 31.15. Randox Laboratories Ltd.

32. Global In Vitro Diagnostics Enzymes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Vitro Diagnostics Enzymes Market

34. Recent Developments In The In Vitro Diagnostics Enzymes Market

35. In Vitro Diagnostics Enzymes Market High Potential Countries, Segments and Strategies

  • 35.1 In Vitro Diagnostics Enzymes Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In Vitro Diagnostics Enzymes Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In Vitro Diagnostics Enzymes Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer